253 related articles for article (PubMed ID: 7684739)
1. Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.
Bubien JK; Zhou LJ; Bell PD; Frizzell RA; Tedder TF
J Cell Biol; 1993 Jun; 121(5):1121-32. PubMed ID: 7684739
[TBL] [Abstract][Full Text] [Related]
2. Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells.
Kanzaki M; Shibata H; Mogami H; Kojima I
J Biol Chem; 1995 Jun; 270(22):13099-104. PubMed ID: 7539422
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane ion conductance in human B lymphocyte activation.
Brent LH; Butler JL; Woods WT; Bubien JK
J Immunol; 1990 Oct; 145(8):2381-9. PubMed ID: 1698853
[TBL] [Abstract][Full Text] [Related]
4. CD20: a regulator of cell-cycle progression of B lymphocytes.
Tedder TF; Engel P
Immunol Today; 1994 Sep; 15(9):450-4. PubMed ID: 7524522
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
6. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
Bradbury LE; Goldmacher VS; Tedder TF
J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
[TBL] [Abstract][Full Text] [Related]
7. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
8. Association of tyrosine and serine kinases with the B cell surface antigen CD20. Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C-gamma 1 and PLC phospholipase C-gamma 2.
Deans JP; Schieven GL; Shu GL; Valentine MA; Gilliland LA; Aruffo A; Clark EA; Ledbetter JA
J Immunol; 1993 Nov; 151(9):4494-504. PubMed ID: 7691952
[TBL] [Abstract][Full Text] [Related]
9. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
[TBL] [Abstract][Full Text] [Related]
10. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
11. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two novel pre-B-cell lines (LK63 and LiLa-1): potential models of pre-B-cell differentiation.
Salvaris E; Novotny JR; Welch K; Campbell L; Boyd AW
Leuk Res; 1992; 16(6-7):655-63. PubMed ID: 1378917
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the B1 (CD20) molecule by normal and malignant human B lymphocytes.
Tedder TF; Schlossman SF
J Biol Chem; 1988 Jul; 263(20):10009-15. PubMed ID: 2454914
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
Sidorenko SP; Clark EA
J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 nef expression inhibits the activity of a Ca2+-dependent K+ channel involved in the control of the resting potential in CEM lymphocytes.
Zegarra-Moran O; Rasola A; Rugolo M; Porcelli AM; Rossi B; Galietta LJ
J Immunol; 1999 May; 162(9):5359-66. PubMed ID: 10228012
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
17. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the cDNA for a hematopoietic cell-specific protein related to CD20 and the beta subunit of the high-affinity IgE receptor: evidence for a family of proteins with four membrane-spanning regions.
Adra CN; Lelias JM; Kobayashi H; Kaghad M; Morrison P; Rowley JD; Lim B
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10178-82. PubMed ID: 7524084
[TBL] [Abstract][Full Text] [Related]
19. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40.
Valentine MA; Licciardi KA
Eur J Immunol; 1992 Dec; 22(12):3141-8. PubMed ID: 1280225
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP has the ability to influence multiple events during B cell stimulation.
Holte H; Torjesen P; Blomhoff HK; Ruud E; Funderud S; Smeland EB
Eur J Immunol; 1988 Sep; 18(9):1359-66. PubMed ID: 2458941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
